Drugs / 17P
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT03297216 Comparator | Feb 2018 → Jun 2020 | HIV infectious disease | University of North Carolina, Chapel Hill | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 17P | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03297216 ↗ |
| Route | Intramuscular | “administered by weekly intramuscular injection” PMID 30813934 ↗ Feb 2019 |